Seeking Alpha

KBIO
  KaloBios Pharmaceuticals - NASDAQ

8/22/2014, 4:15 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
KBIO vs. ETF Alternatives
Company Description
KaloBios Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.